2.2 mg tirzepatide NICE recommends Lilly's for type 2 diabetes treatment Tirzepatide dosage chart in units:

In this, pentadecapeptide BPC 157 consistently (grossly, microscopically, and biomechanically) cured burn injuries, and counteracted corticosteroid (6-methylprednisolone 1.0 or 10 mg/kg/day ip for 21 days)-induced impairment of burn healing (Mikus et al., 2001

This allows a person to establish healthier habits without feeling like they are fighting a constant uphill battle against their own biology

This not only saves excipient costs but also simplifies formulations and reduces the difficulty of quality control

Limitations of Use : Since the long-term cardiovascular safety and potential long-term cardiovascular benefit of tesamorelin treatment have not been studied and are not known, careful consideration should be given whether to continue tesamorelin treatment in patients who do not show a clear efficacy response as judged by the degree of reduction in visceral adipose tissue measured by waist circumference or CT scan

It is also approved for adolescents aged 12 and older, making it unique among the three